| MAnagement of METastatic Disease in Campania (MAMETIC) (NCT04595032) | National Cancer Institute, Naples | 2020-09-11 |
| Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial (NCT05188911) | Fudan University | 2020-07-15 |
| The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid Malignancies (NCT04492735) | Roshni Dasgupta | 2020-06-05 |
| Safety and Targeting of Anti-hk2 Antibody in mCRPC (NCT04116164) | SpectronRX | 2019-09-18 |
| IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study (NCT03705403) | Maastricht University Medical Center | 2019-04-04 |
| Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients (NCT03823989) | Lipomedix Pharmaceuticals Inc. | 2019-01-03 |
| Negative Pressure Wound Therapy vs. Sterile Dressing for Patients Undergoing Thoracolumbar Spine Surgery (NCT03632005) | John Street | 2017-03-18 |
| Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients (NCT01861938) | Hadassah Medical Organization | 2017-03-01 |
| Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN) (NCT02856867) | European Organisation for Research and Treatment of Cancer - EORTC | 2016-12-01 |
| Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary (NCT02628379) | Foundation Medicine | 2015-05-01 |
| A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo (NCT02496832) | University Health Network, Toronto | 2014-11-01 |
| Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab (NCT02175654) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2014-06-01 |
| CPCT-05 Biopsy Protocol Patient Selection (NCT01904916) | P.O. Witteveen | 2014-01-01 |
| Stereotactic Radiation Therapy for Pediatric Sarcomas (NCT01763970) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-11-01 |
| Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer (NCT01875380) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2013-06-01 |
| Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic (NCT01703910) | Centro Nacional de Investigaciones Oncologicas CARLOS III | 2012-11-01 |
| BIBW 2992 as add-on to Gem/Cis in Advanced Biliary Tract Cancer (NCT01679405) | Johannes Gutenberg University Mainz | 2012-08-01 |
| Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy (NCT01484860) | University Health Network, Toronto | 2012-01-01 |
| CPCT-02 Biopsy Protocol (NCT01855477) | Foundation CPCT | 2011-08-17 |
| Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy (NCT01450683) | Stanford University | 2010-09-01 |
| Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer (NCT01020305) | Sandy Srinivas | 2009-10-01 |
| Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST) (NCT01089595) | Fox Chase Cancer Center | 2009-02-01 |
| Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors (NCT00369785) | Wake Forest University Health Sciences | 2008-02-01 |
| Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal (NCT00480389) | University Health Network, Toronto | 2007-05-01 |
| Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC) (NCT00609401) | Italian Trial in Medical Oncology | 2006-11-01 |
| Study Using High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue Masses, Lymph Node, or Bone (NCT00678158) | Memorial Sloan Kettering Cancer Center | 2006-08-01 |
| Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen (NCT00532454) | National Cancer Center, Korea | 2006-06-01 |
| Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma (NCT00406900) | Ludwig-Maximilians - University of Munich | 1999-01-01 |